Next Article in Journal
Corneal Behavior during Tonometer Measurement during the Water Drinking Test in Eyes with XEN GelStent in Comparison to Non-Implanted Eyes
Previous Article in Journal
The Non-Concordance of Self-Reported and Performance-Based Measures of Vestibular Dysfunction in Military and Civilian Populations Following TBI
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Assessment of the Retinal Vessels in Keratoconus: An OCT Angiography Study

1
Health Promotion and Obesity Management Unit, Department of Pathophysiology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-635 Katowice, Poland
2
Ophthalmology Department, Railway Hospital, 40-760 Katowice, Poland
3
School of Medicine with the Division of Dentistry, Zabrze Medical University of Silesia, 40-055 Katowice, Poland
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2022, 11(11), 2960; https://0-doi-org.brum.beds.ac.uk/10.3390/jcm11112960
Submission received: 19 April 2022 / Revised: 20 May 2022 / Accepted: 23 May 2022 / Published: 24 May 2022
(This article belongs to the Section Ophthalmology)

Abstract

:
This study investigated vascular density and foveal avascular zone (FAZ) parameters using optical coherence tomography angiography (OCT-A) in patients with keratoconus (KC). Participants with KC and healthy controls were included and underwent best-corrected visual acuity (BCVA), keratometry, anterior segment OCT, and macular OCT-A examinations. Of the 70 subjects (mean age 42.9 ± 15.31 years), 79 KC and 47 healthy eyes were included. Significant reductions in the KC group were recorded for the FAZ area, with a mean (±SD) of 0.19 ± 0.12 vs. 0.25 ± 0.09 mm2 p < 0.001. Central vascular density in KC patients was lower compared with the controls: 6.78 ± 4.74 vs. 8.44 ± 3.33 mm−1 p = 0.049; the inner density was also decreased in the study group (13.64 ± 5.13 vs. 16.54 ± 2.89 mm−1, p = 0.002), along with the outer density (14.71 ± 4.12 vs. 16.88 ± 2.42 mm−1, p = 0.004) and full density (14.25 ± 4.30 vs. 16.57 ± 2.48) p = 0.003. Furthermore, BCVA was positively correlated with central vascular density (R = 0.42 p = 0.004, total R = 0.40, p = 0.006) and inner density (R = 0.44, p = 0.002) in patients with KC but not in controls. Additionally, we found a correlation between K2 and inner vascular density (R = −0.30, p = 0.043) and central epithelium thickness and outer density (R = 0.03, p = 0.046). KC patients had lower macular vascular density and a smaller FAZ than healthy participants. The BCVA in KC patients was correlated with the vascular density.

1. Introduction

Keratoconus (KC) is a progressive, ectatic cornea disease with a multifactorial etiology. The essence of this condition is a thinning and protrusion of the cornea, which leads to irregular astigmatism and, often, significant visual impairment. Treatment options for this disease include correction with rigid gas-permeable contact lenses; intracorneal stromal rings; collagen cross-linking (CXL), which slows the progression of the disease; and corneal transplant [1,2]. Symptoms typically occur in adolescence, with corneal thinning and steepening progression until the fourth decade of life. The pathophysiology and etiology of this condition are not fully understood. Researchers have indicated the contribution of genetic and environmental factors, with different biochemical processes and histopathological changes involved. A reduction in the number of stromal keratocytes and collagen fibrils, often with concomitant ruptures in Bowman’s layer and central epithelial thinning with irregular cells, is observed in KC [3]. A decrease in collagen fibril diameter and an increase in proteoglycans have been described in the disease [4]. The condition is classified as non-inflammatory; however, recent studies have demonstrated the presence of proinflammatory cytokines and collagenase in the tear film of patients [5,6]. Since collagen is the major protein of the cornea, the assumption that collagenase enzymes are involved is justified. Although most KC cases are sporadic, numerous genes have been assessed regarding their role in pathogenesis, including the collagen gene [7,8,9]. Associations between KC and many other syndromes and disorders have been described. Additionally, many connective tissue diseases correlate with KC, such as osteogenesis imperfecta, Ehlers–Danlos syndrome, Marfan syndrome, mitral valve prolapse, Mediterranean fever, and joint hypermobility disease, as reported in other studies [3,10]. Alterations in choroidal, stromal, and vascular areas in patients with KC have also been demonstrated [11,12]. KC patients have thicker choroids than healthy controls, which could be associated with the inflammatory mechanism of the disorder [12,13]. Nevertheless, the meaning and cause of these changes remain unclear. Abnormalities and the distribution of collagen lamellae, an essential component of vessels, have been demonstrated in KC. OCT angiography (OCT-A) is a non-invasive imaging tool that allows detailed visualization of the retinal microvasculature to be obtained. Therefore, in this study, we compared the retinal vascularization and corneal parameters of patients with diagnosed KC with those of a control group using SS-OCT [14,15,16].

2. Materials and Methods

This observational study included an analysis of 126 eyes performed in the university clinic. This study included 31 women and 39 men. The patients were recruited from the cornea and refractive surgery ambulatory center of the Railway Hospital, Katowice, Poland, presenting for ocular examination. Out of 79 eyes with KC, 45 were previously treated with collagen cross-linking (CXL) at least 14 months before inclusion in the study, and two had intracorneal rings implanted. The mean ± SD preoperative BCVA was 0.23 ± 0.56 logMAR, and the BCVA was 0.17 ± 0.55 logMAR 12 months after the procedure. All the imaging procedures were performed between January 2019 and June 2020. Our study followed the principles of the Declaration of Helsinki, with ethics approval obtained from the Medical University of Silesia Institutional Review Board. The study included 42 KC patients and 28 healthy controls. The current best-corrected visual acuity (BCVA) was measured on the basis of the manifest refraction during the visit.
All patients had a slit-lamp examination and indirect ophthalmoscopy. Patients with no anterior segment disorders other than KC and no posterior segment diseases, such as glaucoma, posterior staphyloma, choroidal neovascularization (CNV), diabetic retinopathy, vascular occlusions, and other retinal dysfunctions, were included. Keratometry and refraction were calculated on a Keratometer KR-1W (Topcon, Tokyo, Japan) Cirrus 5000 (Carl Zeiss Meditec, Dublin, CA, USA), and Angioplex software v 11 was utilized to create OCT angiograms and anterior segment maps with an add-on lens. Central corneal thickness (CCT) and epithelial thickness were calculated using a pachymetry scan. K1 and K2 were calculated using Tomey KR-1W. Each patient had a 6 × 6 mm OCT angiography scan. The Zeiss Angioplex software automatically calculated all OCT-A parameters. Only scans with a quality of more than 7/10 were included in the study. The following parameters were calculated: vascular density and the total vessel length divided by the specific area on a standard 6.0 mm ETDRS map (central 1 mm, inner 3 mm without the center 1 mm, outer 6 mm without the inner and center, and total area of the ETDRS circle). FAZ was described by the size of the three parameters in mm2 diameter, that is, a straight line connecting two furthest points and running through the center of FAZ described in mm, and circularity (roundness), which is a value representing how close a shape is to a perfect circle, where 1 represents an ideal circle and 0 represents a straight line [17]. Angioplex displays the vascular density as mm/mm2; for conciseness, we used the mm−1 notation.
Standard spectral domain OCT scans, including optic nerve 200 × 200 scans and 512 × 512 macular cube scans, were acquired. Posterior scans were obtained after instilling one drop of Tropicamide (Polpharma, Warsaw, Poland). Patients wearing contact lenses were told to abstain from wearing them for 72 h before the examination. Only Polish Caucasians without systemic diseases were included in the analysis to minimize confounding factors. Furthermore, the age and gender did not differ significantly. All measurements were carried out between 14:00 and 17:00.

Statistical Analysis

Categorical variables were analyzed using chi-square tests. The normality of the data was measured using the Shapiro–Wilk test. Continuous variables were analyzed using analysis of variances (ANOVA). The association between continuous variables was investigated with Pearson’s correlation. We nested the ANOVA for this factor to eliminate bilaterality as a confounding variable. The correlation between the quality index and OCT-A parameters was also tested. Multiple regression was performed to test whether the CXL affected the vascular parameters. Values of <0.05 were considered significant. Statistical analyses were performed using Statistica 13.3 (Tibco, Palo Alto, CA, USA).

3. Results

Of the 138 OCT-A scans taken, 8% (8 in KC patients and 4 in controls) were considered below the required quality. The mean age of KC patients was 43.64 ± 15.30 vs. 40.10 ± 14.28 years (Table 1).
Most KC eyes were stage 0 or I, 11 eyes were stage III, and only 10 eyes had parameters classified as stage IV (Figure 1). BCVAs were significantly different between the KC group and the control group and were 0.97± 0.08 and 0.62 ± 0.29, respectively (p < 0.001, logMAR: 0.02 ± 0.92 vs. 0.20 ± 0.52).
The mean spherical power in the KC group was −0.89 ± 4.08 D, while the control refractive error was −1.75 ± 2.02 D; the differences were insignificant, contrary to cylindrical power, with a mean of −3.30 ± 2.46 D in KC subjects and −0.92 ± 0.83 D in the normal population (p = 0.001).
The average K1 was 44.41 ± 3.92 D in the KC group and 43.22 ± 0.75 in the control group, and the differences were marginally non-significant (p = 0.057). However, there was a significant difference between the mean CCTs, which was 478.58 ± 45.27 µm in KC patients and 538.66 ± 29.14 µm (p < 0.001) in unaffected individuals.
Other significant changes were observed in the rim area (1.49 ± 0.36 vs. 1.29 ± 0.20, p < 0.001), disc area (2.02 ± 0.39 vs. 1.71 ± 0.36, p < 0.001), and central corneal epithelium (44.52 ± 7.02 µm vs. 48.83 ± 7.34 µm, p = 0.002) in patients with KC vs. controls, respectively. In addition, differences between the minimum and maximum epithelium thickness were almost double for KC (−10.22 ± 6.22 µm vs. −5.17 ± 2.71 µm, p = <0.001).
All OCT-A parameters were significantly different between the groups. The difference in central density was marginally significant, with a p-value of 0.049 (6.78 ± 4.74 mm−1 vs. 8.44 ± 4.33 mm−1). The values of KC measurements compared with control measurements for inner, outer, and full density were much lower: 13.64 ± 5.13 mm−1 vs. 16.54 ± 2.89 mm−1, p = 0.002; 14.71 ± 4.12 mm−1 vs. 16.88 ± 2.42 mm−1, p = 0.004; and 14.25 ± 4.30 mm−1 vs. 16.57 ± 2.48 mm−1, p = 0.003, respectively (Table 2).
Overall, in KC group, we observed a negative correlation between age and BCVA (R = −0.46, p = 0.001), and RNFL symmetry (R = −0.49, p = 0.001), while a positive correlation was observed between K1 and age (R = 0.33, p = 0.026). In addition, we found strong positive correlations between the densities measured on the ETDRS circle (range of R = 0.91–0.99). RNFL thickness was significantly correlated with vascular densities in the KC group (range of R = 0.39–0.49) (Table 3).
Further significant correlations were observed between cylinder power and inner, outer, and total vascular density (range of R = 0.40–0.48). BCVA was positively correlated with densities in KC patients but not in healthy controls (Table 4); correlations ranged from r = 0.37 to 0.44 (Table 3). There was no significant correlation between the age, sphere, K1, RNFL symmetry, epithelium max–min, rim and disc area, c/d average, or OCT-A parameters in the KC group. In addition, in controls, neither age, K1, K2, epithelium cube volume, disc area rim area, sphere, cylinder, axis, nor RNFL symmetry was correlated with OCT-A measurements.
Generally, the correlation between the OCT-A and corneal parameters in KC patients was weak or non-significant. The only correlation found was between K2 and inner vascular density (R = −0.30, p = 0.043) and central epithelium thickness and outer density (R = 0.03, p = 0.046). There was a very high correlation between RNFL symmetry and the inner, outer, and total vascular density in controls (range of R = 0.92–0.97).
Furthermore, the quality index showed no significant correlation between vascular parameters in the KC or the control group.

Multiple Regression

No significant association was found between the FAZ area, diameter, and circularity; central, inner, and outer density; or a previous CXL procedure (p = 0.44). Furthermore, the analysis revealed that KC staging was not associated with the vascular density parameters (p = 0.17).

4. Discussion

We showed that OCT-A parameters were significantly different between patients with KC and healthy controls. Another interesting finding was that BCVA was positively associated with vascular density, suggesting a possible link between the architecture of the vessels and visual function. As the BCVA in the KC group was significantly lower because of significant astigmatism, decreased vascular density might have impaired retinal function.
KC is a chronic ectatic disease of the cornea. The onset of KC usually begins in the second decade of life. Many hypotheses regarding the origin of this disorder have been proposed, including an inflammatory origin [6]. In addition, KC has been associated with basement membrane distortion [5], sleep apnea, Down syndrome, and allergic diseases, such as asthma, allergic conjunctivitis, and allergic rhinitis [18]. However, a large study showed no association between sleep apnea and KC [19].
Some alterations in posterior segment abnormalities in patients with KC have also been reported. For example, the subfoveal choroidal thickness was significantly higher in patients with KC (427.48 ± 78.51 μm) than in controls (351.03 ± 99.08 μm) [11]. Another paper showed a higher CMT in patients with KC (363.9 ± 59.8 μm and 328.4 ±  67.2 μm) [12]. However, no difference in CMT was reported in a study on 44 patients with KC and an equal number of healthy participants [20]. Similarly, we did not detect any significant changes between the CMTs in these two groups. Another study analyzed the CMT and electroretinographic findings in patients with KC. The CMT showed no difference. However, the retinal response density in multifocal electroretinography differed significantly [21]. Again, this may suggest impaired macular function.
Flatter corneal curvature was inversely associated with macular thickness in Asians [22]. However, Yang et al. found no correlation between corneal thickness and vascular densities in myopic patients [23].
KC staging had no impact on vascular density parameters (p = 0.17). Therefore, we can speculate that although we found a correlation between BCVA and OCT-A parameters, the analysis did not reveal any correlation between keratometry or CCT and vascular density.
Correlations between OCT-A parameters and the BCVA have been found in studies on other diseases, such as pathological myopia and diabetic retinopathy [24,25]. Furthermore, a correlation between retinal flow disorders and the integrity of the photoreceptors was demonstrated in a study performed by Scarinci et al. [26]. The importance of choroidal circulation in retinal function is supported by the fact that it supplies most of the outer retina, including the photoreceptors. Nevertheless, the contribution of the retinal circulation to photoreceptor metabolism is present [27]. As mentioned, the retinal and choroidal plexus influence visual acuity and retinal function; therefore, the demonstrated correlation between BCVA and superficial plexus density has justification and should be further investigated.
A possible mechanism for the vascular changes occurring in KC is basement membrane destruction. Mutations in TIMP-3 and several other genes have been observed in KC. TIMP-3 is an important gene involved in retinal pigment epithelium remodeling [2,28]. Lacquer cracks in the retina and subretinal hemorrhages with CNV were observed in a patient with bilateral KC with hydrops in one eye [29].
Similarly, lower vascular density was observed in non-glaucomatous eyes with exfoliation syndrome (XSF) than in healthy ones. Like KC, XFS is also a disorder characterized by basement membrane damage [30]. In a study on ocular sarcoidosis, Cerquaglia et al. observed lower vascular density in the retina and choriocapillaris in sarcoid eyes. Changes in the FAZ area were not significant [31]. The authors hypothesized that the differences mentioned above might be explained by inflammatory ischemia.
Traditional methods for detecting KC include slit-lamp examination and corneal topography using either a Scheimpflug camera or modern optical coherence tomography. However, since its introduction in diagnosing anterior segment diseases, OCT has become more and more helpful in diagnosing the KC [32,33]. Contrary to Scheimpflug technology, OCT offers high-resolution images that may help establish the diagnosis [33]. In addition, OCT angiography is a relatively new update to OCT that allows accurate imaging of the vasculature in the posterior pole without injecting a dye. This technology has proven to be helpful in studying both the physiology of the retina and disorders [34].
Various factors affect OCT-A density, such as signal strength [35], ethnicity [17], high myopia [36], and neurological diseases [16]. Contrary to choroidal thickness, circadian rhythm has little effect on the parafoveal density [37]. Furthermore, reports regarding age and gender effects on OCT-A parameters are contradictory [34,38,39,40].
A potential limitation of the current study is the inclusion of both eyes. However, it is possible to use a nested ANOVA model and have both eyes in the study [41,42]. Additionally, we only evaluated the vascular densities in the superficial plexus. However, Angioplex automatically provides information about only the superficial plexus. Secondly, in an animal study, Campbell et al. demonstrated that all the vascular layers merged into one to create a single FAZ [43]. Furthermore, we did not assess the posterior surface of the cornea. Although some studies have shown a correlation between axial length and vascular parameters, we did not measure axial length, as both of our groups were myopic [44,45].
In conclusion, our study suggests a significant decrease in macular vascular density in KC patients. Therefore, in the pathophysiology of visual impairment in KC, a macular vascular disorder that is not visible ophthalmoscopically may coexist with the corneal abnormality. Future studies should address the correlation between the severity of KC and vascular changes.

Author Contributions

Conception and design of the work: A.W., D.S., R.F. and E.W. Data collection: A.W. and D.S. Data analysis and interpretation: A.W., D.S., R.F. and E.W. Drafting the article: A.W., D.S. and R.F. Critical revision of the article: A.W., D.S., R.F. and E.W. Final approval: A.W., D.S., R.F. and E.W. All authors have read and agreed to the published version of the manuscript.

Funding

This paper was supported by NCN grant 2020/04/X/NZ4/00440.

Institutional Review Board Statement

This study was approved by the Ethics Committee of the 183 Silesian Medical University KNW/0022/KB1/47/I/17 (13 December 2016).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Data are available upon reasonable request.

Conflicts of Interest

A.W. received speaker honoraria from Carl Zeiss Meditec and Optopol technology; the rest of the authors have nothing to declare.

References

  1. Roszkowska, A.M.; Wylegala, E. Corneal Degenerations. In Oxidative Stress in Applied Basic Research and Clinical Practice; Humana Press: New York, NY, USA, 2015; pp. 23–38. [Google Scholar]
  2. Sharif, R.; Bak-Nielsen, S.; Hjortdal, J.; Karamichos, D. Pathogenesis of Keratoconus: The Intriguing Therapeutic Potential of Prolactin-Inducible Protein. Prog. Retin. Eye Res. 2018, 67, 150–167. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Tur, V.M.; MacGregor, C.; Jayaswal, R.; O’Brart, D.; Maycock, N. A Review of Keratoconus: Diagnosis, Pathophysiology, and Genetics. Surv. Ophthalmol. 2017, 62, 770–783. [Google Scholar]
  4. Panahi, Y.; Azimi, A.; Naderi, M.; Jadidi, K.; Sahebkar, A. An Analytical Enrichment-Based Review of Structural Genetic Studies on Keratoconus. J. Cell. Biochem. 2019, 120, 4748–4756. [Google Scholar] [CrossRef] [PubMed]
  5. Kryczka, T.; Ehlers, N.; Nielsen, K.; Wylegala, E.; Dobrowolski, D.; Midelfart, A. Metabolic Profile of Keratoconic Cornea. Curr. Eye Res. 2013, 38, 305–309. [Google Scholar] [CrossRef] [PubMed]
  6. García, B.; García-Suárez, O.; Merayo-Lloves, J.; Ferrara, G.; Alcalde, I.; González, J.; Lisa, C.; Alfonso, J.F.; Vazquez, F.; Quirós, L.M. Heparanase Overexpresses in Keratoconic Cornea and Tears Depending on the Pathologic Grade. Dis. Markers 2017, 2017, 3502386. [Google Scholar] [CrossRef] [Green Version]
  7. Bykhovskaya, Y.; Margines, B.; Rabinowitz, Y.S. Genetics in Keratoconus: Where Are We? Eye Vis. 2016, 3, 16. [Google Scholar] [CrossRef] [Green Version]
  8. Priyadarsini, S.; McKay, T.B.; Sarker-Nag, A.; Karamichos, D. Keratoconus In Vitro and the Key Players of the TGF-β Pathway. Mol. Vis. 2015, 21, 577. [Google Scholar]
  9. Karamichos, D. Keratoconus: Challenges and Emerging Trends. J. Mol. Genet. Med. 2018, 12, 367. [Google Scholar] [CrossRef]
  10. Kalkan Akcay, E.; Akcay, M.; Uysal, B.S.; Kosekahya, P.; Aslan, A.N.; Caglayan, M.; Koseoglu, C.; Yulek, F.; Cagil, N. Impaired Corneal Biomechanical Properties and the Prevalence of Keratoconus in Mitral Valve Prolapse. J. Ophthalmol. 2014, 2014, 402193. [Google Scholar] [CrossRef] [Green Version]
  11. Akkaya, S. Macular and Peripapillary Choroidal Thickness in Patients With Keratoconus. Ophthalmic Surg. Lasers Imaging Retin. 2018, 49, 664–673. [Google Scholar] [CrossRef]
  12. Bilgin, B.; Karadag, A.S. Choroidal Thickness in Keratoconus. Int. Ophthalmol. 2020, 40, 135–140. [Google Scholar] [CrossRef] [PubMed]
  13. Pinheiro-Costa, J.; Viana Pinto, J.; Perestrelo, S.; Beato, J.N.; Torrão, L.; Brandão, E.; Carneiro, Â.; Madeira, M.D.; Falcão-Reis, F. Increased Choroidal Thickness in Keratoconus Patients: Perspectives in the Disease Pathophysiology. J. Ophthalmol. 2019, 2019, 2453931. [Google Scholar] [CrossRef] [PubMed]
  14. Gutierrez-Bonet, R.; Ruiz-Medrano, J.; Biarnés, M.; Rasheed, M.A.; Vupparaboina, K.K.; Chhablani, J.; Ruiz-Moreno, J.M. Analysis of Choroidal Vascularity Index in Keratoconus Patients Using Swept-Source Optical Coherence Tomography-Based Binarization Techniques. J. Ophthalmol. 2020, 2020, 1682463. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Wylęgała, A.; Bolek, B.; Wylęgała, E. Trends in Optical Coherence Tomography Angiography Use in University Clinic and Private Practice Setting between 2014–2018. Expert Rev. Med. Devices 2020, 17, 1109–1113. [Google Scholar] [CrossRef] [PubMed]
  16. Wylęgała, A. Principles of OCTA and Applications in Clinical Neurology. Curr. Neurol. Neurosci. Rep. 2018, 18, 96. [Google Scholar] [CrossRef] [Green Version]
  17. Wylęgała, A.; Wang, L.; Zhang, S.; Liu, Z.; Teper, S.; Wylęgała, E. Comparison of Foveal Avascular Zone and Retinal Vascular Density in Healthy Chinese and Caucasian Adults. Acta Ophthalmol. 2019, 98, e464–e469. [Google Scholar] [CrossRef]
  18. Lee, H.K.; Jung, E.H.; Cho, B.J. Epidemiological Association Between Systemic Diseases and Keratoconus in a Korean Population: A 10-Year Nationwide Cohort Study. Cornea 2020, 39, 348–353. [Google Scholar] [CrossRef]
  19. Lin, K.K.; Lee, J.S.; Hou, C.H.; Chen, W.M.; Hsiao, C.H.; Chen, Y.W.; Yeh, C.T.; See, L.C. The Sociodemographic and Risk Factors for Keratoconus: Nationwide Matched Case-Control Study in Taiwan, 1998–2015. Am. J. Ophthalmol. 2021, 223, 140–148. [Google Scholar] [CrossRef]
  20. Deonarain, S.; Motala, A.; Mthembu, T.; Nxele, N.; Phakathi, T.; Gcabashe, N.; Rampersad, N. Macular Thicknesses in Patients with Keratoconus: An Optical Coherence Tomography Study. Afr. Vis. Eye Health 2019, 78, 1–8. [Google Scholar] [CrossRef]
  21. Moschos, M.M.; Chatziralli, I.P.; Koutsandrea, C.; Siasou, G.; Droutsas, D. Assessment of the Macula in Keratoconus: An Optical Coherence Tomography and Multifocal Electroretinography Study. Ophthalmologica 2013, 229, 203–207. [Google Scholar] [CrossRef]
  22. Wong, K.H.; Tham, Y.C.; Nguyen, D.Q.; Dai, W.; Tan, N.Y.Q.; Mathijia, S.; Neelam, K.; Cheung, C.Y.L.; Sabanayagam, C.; Schmetterer, L.; et al. Racial Differences and Determinants of Macular Thickness Profiles in Multiethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study. Br. J. Ophthalmol. 2019, 103, 894–899. [Google Scholar] [CrossRef] [PubMed]
  23. Yang, S.; Zhou, M.; Lu, B.; Zhang, P.; Zhao, J.; Kang, M.; Wang, R.; Wang, F.; Sun, X. Quantification of Macular Vascular Density Using Optical Coherence Tomography Angiography and Its Relationship with Retinal Thickness in Myopic Eyes of Young Adults. J. Ophthalmol. 2017, 2017, 1397179. [Google Scholar] [CrossRef] [PubMed]
  24. Abdelshafy, M.; Abdelshafy, A. Correlations between Optical Coherence Tomography Angiography Parameters and the Visual Acuity in Patients with Diabetic Retinopathy. Clin. Ophthalmol. 2020, 14, 1107–1115. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Ye, J.; Wang, M.; Shen, M.; Huang, S.; Xue, A.; Lin, J.; Fan, Y.; Wang, J.; Lu, F.; Shao, Y. Deep Retinal Capillary Plexus Decreasing Correlated with the Outer Retinal Layer Alteration and Visual Acuity Impairment in Pathological Myopia. Investig. Ophthalmol. Vis. Sci. 2020, 61, 45. [Google Scholar] [CrossRef]
  26. Scarinci, F.; Nesper, P.L.; Fawzi, A.A. Deep Retinal Capillary Nonperfusion Is Associated with Photoreceptor Disruption in Diabetic Macular Ischemia. Am. J. Ophthalmol. 2016, 168, 129–138. [Google Scholar] [CrossRef] [Green Version]
  27. Linsenmeier, R.A.; Zhang, H.F. Retinal Oxygen: From Animals to Humans. Prog. Retin. Eye Res. 2017, 58, 115–151. [Google Scholar] [CrossRef] [Green Version]
  28. Matthews, F.J.; Cook, S.D.; Majid, M.A.; Dick, A.D.; Smith, V.A. Changes in the Balance of the Tissue Inhibitor of Matrix Metalloproteinases (TIMPs)-1 and -3 May Promote Keratocyte Apoptosis in Keratoconus. Exp. Eye Res. 2007, 84, 1125–1134. [Google Scholar] [CrossRef]
  29. Oh, J.Y.; Yu, H.G. Keratoconus Associated with Choroidal Neovascularization: A Case Report. J. Med. Case Rep. 2010, 4, 2–5. [Google Scholar] [CrossRef] [Green Version]
  30. Gür Güngör, S.; Sarigül Sezenöz, A.; Öztürk, C.; Gökgöz, G.; Akman, A. Peripapillary and Macular Vessel Density Measurement with Optical Coherence Tomography Angiography in Exfoliation Syndrome. J. Glaucoma 2021, 30, 71–77. [Google Scholar] [CrossRef]
  31. Cerquaglia, A.; Iaccheri, B.; Fiore, T.; Fruttini, D.; Belli, F.B.; Khairallah, M.; Lupidi, M.; Cagini, C. New Insights on Ocular Sarcoidosis: An Optical Coherence Tomography Angiography Study. Ocul. Immunol. Inflamm. 2019, 27, 1057–1066. [Google Scholar] [CrossRef]
  32. Wylegała, E.; Teper, S.; Nowińska, A.K.; Milka, M.; Dobrowolski, D. Anterior Segment Imaging: Fourier-Domain Optical Coherence Tomography versus Time-Domain Optical Coherence Tomography. J. Cataract Refract. Surg. 2009, 35, 1410–1414. [Google Scholar] [CrossRef] [PubMed]
  33. Wylȩgała, A.; Mazur, R.; Bolek, B.; Wylȩgała, E. Reproducibility, and Repeatability of Corneal Topography Measured by Revo NX, Galilei G6 and Casia 2 in Normal Eyes. PLoS ONE 2020, 15, e0230589. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Spaide, R.F.; Fujimoto, J.G.; Waheed, N.K.; Sadda, S.R.; Staurenghi, G. Optical Coherence Tomography Angiography. Prog. Retin. Eye Res. 2018, 64, 1–55. [Google Scholar] [CrossRef] [PubMed]
  35. Bansal, T.; Dubey, S.; Rao, H.L.; Gandhi, M.; Pegu, J. Predictors of Peripapillary and Macular Optical Microangiography Measurements in Healthy Eyes. J. Glaucoma 2021, 30, 697–702. [Google Scholar] [CrossRef] [PubMed]
  36. Wong, C.W.; Matsumura, S.; Htoon, H.M.; Tan, S.; Tan, C.S.; Ang, M.; Wong, Y.L.; Agrawal, R.; Sabanayagam, C.; Saw, S.M. Assessment of the Macular Microvasculature in High Myopes With Swept Source Optical Coherence Tomographic Angiography. Front. Med. 2021, 8, 619767. [Google Scholar] [CrossRef]
  37. Verticchio Vercellin, A.C.; Harris, A.; Tanga, L.; Siesky, B.; Quaranta, L.; Rowe, L.W.; Torabi, R.; Agnifili, L.; Riva, I.; Oddone, F. Optic Nerve Head Diurnal Vessel Density Variations in Glaucoma and Ocular Hypertension Measured by Optical Coherence Tomography Angiography. Graefe’s Arch. Clin. Exp. Ophthalmol. 2020, 258, 1237–1251. [Google Scholar] [CrossRef]
  38. Polascik, B.W.; Thompson, A.C.; Yoon, S.P.; Powers, J.H.; Burke, J.R.; Grewal, D.S.; Fekrat, S. Association of OCT Angiography Parameters with Age in Cognitively Healthy Older Adults. In Proceedings of the Ophthalmic Surgery Lasers and Imaging Retina; Slack Incorporated, Moshfeghi, MD, USA, 1 December 2020; Volume 51, pp. 706–714. [Google Scholar]
  39. Alnawaiseh, M.; Brand, C.; Lauermann, J.L.; Eter, N. Flow Density Measurements Using Optical Coherence Tomography Angiography: Impact of Age and Gender. Ophthalmologe 2018, 115, 659–662. [Google Scholar] [CrossRef]
  40. Wylęgała, A.; Teper, S.; Dobrowolski, D.; Wylęgała, E. Optical Coherence Angiography: A Review. Medicine 2016, 95, e4907. [Google Scholar] [CrossRef]
  41. Armstrong, R.A. Statistical Guidelines for the Analysis of Data Obtained from One or Both Eyes. Ophthalmic Physiol. Opt. 2013, 33, 7–14. [Google Scholar] [CrossRef]
  42. Fan, Q.; Teo, Y.Y.; Saw, S.M. Application of Advanced Statistics in Ophthalmology. Investig. Ophthalmol. Vis. Sci. 2011, 52, 6059–6065. [Google Scholar] [CrossRef]
  43. Campbell, J.P.; Zhang, M.; Hwang, T.S.; Bailey, S.T.; Wilson, D.J.; Jia, Y.; Huang, D. Detailed Vascular Anatomy of the Human Retina by Projection-Resolved Optical Coherence Tomography Angiography. Sci. Rep. 2017, 7, 42201. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Park, K.S.; Lim, H.; Bin Shin, Y., II; Park, G.S.; Lee, W.H.; Kim, J.Y. Effect of Axial Length on Peripapillary Microvasculature: An Optical Coherence Tomography Angiography Study. PLoS ONE 2021, 16, e0258479. [Google Scholar] [CrossRef] [PubMed]
  45. Gołębiewska, J.; Biała-Gosek, K.; Czeszyk, A.; Hautz, W. Optical Coherence Tomography Angiography of Superficial Retinal Vessel Density and Foveal Avascular Zone in Myopic Children. PLoS ONE 2019, 14, e0219785. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. Classification of the eyes included in the study group according to ABCD classification.
Figure 1. Classification of the eyes included in the study group according to ABCD classification.
Jcm 11 02960 g001
Table 1. Qualitative variables of patients with keratoconus and healthy controls who qualified for the study. The data were compared using the chi-squared (c2) test. Statistical significance was set at p < 0.05.
Table 1. Qualitative variables of patients with keratoconus and healthy controls who qualified for the study. The data were compared using the chi-squared (c2) test. Statistical significance was set at p < 0.05.
LateralityOSODAll Groupsc2p
GroupControl2027470.549p = 0.459
GroupKeratoconus394079
RowTotals5967126
GenderFMTotals
GroupControl1612283.127p = 0.077
GroupKeratoconus152742
RowAll Groups313970
Table 2. Quantitative variables of patients with keratoconus and healthy controls who qualified for the study. Statistical significance was set at p < 0.05.
Table 2. Quantitative variables of patients with keratoconus and healthy controls who qualified for the study. Statistical significance was set at p < 0.05.
Control GroupKeratoconus Group
VariableMeanSDMeanSDp
Age42.4016.9943.2214.24p = 0.683
BCVA0.940.120.630.30p < 0.001
BCVA LogMAR0.020.920.200.52p < 0.001
K143.250.7444.673.85p = 0.002
K243.880.6747.854.66p < 0.001
FAZ area0.250.090.200.12p < 0.001
Perimeter2.090.391.860.63p = 0.001
Circularity0.720.100.710.09p =0.146
Central8.443.336.784.74p = 0.049
Inner16.542.8913.645.13p = 0.002
Outer16.882.4214.714.12p = 0.004
Full16.572.4814.254.30p = 0.003
Epithelium center48.837.3444.527.02p = 0.002
Epithelium min-max−5.172.71−10.226.22p < 0.001
CCT538.6629.14478.5845.27p < 0.001
CCTmin518.2636.78425.49106.86p < 0.001
CMT258.0019.00255.3425.35p = 0.936
Volume cube10.010.6211.3310.23p = 0.107
RNFL90.267.7491.1614.28p = 0.101
RNFL symmetry81.5611.8372.7822.16p = 0.079
Rim area1.290.201.490.36p < 0.001
Disc area1.710.362.020.39p < 0.001
Cup volume0.120.100.140.18p = 0.603
c/d average0.450.160.470.17p = 0.232
Sphere−1.752.02−0.894.08p = 0.163
Cylinder−0.920.83−3.302.46p = 0.001
Axis110.2242.6890.9754.93p = 0.400
Table 3. Pearson correlation matrix for tested variables in KC patients. Statistically significant values are marked in red.
Table 3. Pearson correlation matrix for tested variables in KC patients. Statistically significant values are marked in red.
Group = Keratoconus
VariableBCVAK2EpiCCTCCT
min
Faz
Area
PerimeterCircularityCentralInnerOuterFullCMTRNFLCup
Volume
CylinderAxis
BCVA1−0.640.190.30.17−0.07−0.150.150.410.440.370.40.090.150.180.380.05
K2−0.641−0.46−0.34−0.280.030.08−0.13−0.26−0.3−0.21−0.24−0.21−0.06−0.27−0.54−0.04
Epi0.19−0.4610.510.350.010.05−0.020.180.250.30.28−0.150.320.070.52−0.07
CCT0.3−0.340.5110.770.08−0.020.160.240.290.330.32−0.110.070.050.43−0.36
CCTmin0.17−0.280.350.7710.190.090.080.110.250.30.28−0.070.020.040.32−0.35
Faz area−0.070.030.010.080.1910.93−0.33−0.290.050.160.12−0.670.26−0.29−0.13−0.21
Perimeter−0.150.080.05−0.020.090.931−0.59−0.340.010.110.07−0.670.23−0.3−0.1−0.17
Circularity0.15−0.13−0.020.160.08−0.33−0.5910.30.070.050.060.330.070.19−0.020.03
Central0.41−0.260.180.240.11−0.29−0.340.310.870.810.840.470.21−0.130.4−0.14
Inner0.44−0.30.250.290.250.050.010.070.8710.960.980.170.41−0.250.48−0.22
Outer0.37−0.210.30.330.30.160.110.050.810.96110.050.49−0.280.44−0.31
Full0.4−0.240.280.320.280.120.070.060.840.98110.10.46−0.270.45−0.29
CMT0.09−0.21−0.15−0.11−0.07−0.67−0.670.330.470.170.050.11−0.390.090.06−0.02
volume cube0.070.01−0.1500.04−0.24−0.240.080.05−0.02−0.06−0.040.160.170.15−0.060.15
RNFL0.15−0.060.320.070.020.260.230.070.210.410.490.460.3910.030.190.04
Cup volume0.18−0.270.070.050.04−0.29−0.30.19−0.13−0.25−0.28−0.270.090.0310.060.28
Cylinder0.38−0.540.520.430.32−0.13−0.1−0.020.40.480.440.450.060.190.061−0.12
Axis0.05−0.04−0.07−0.36−0.35−0.21−0.170.03−0.14−0.22−0.31−0.29−0.020.040.28−0.121
Epi—epithelium center, CCT—central corneal thickness, CMT—central macular thickness, RNFL—retinal nerve fiber layer, BCVA—best-corrected visual acuity, FAZ—foveal avascular zone.
Table 4. Pearson correlation matrix for tested variables in healthy controls. Statistically significant values are marked in red.
Table 4. Pearson correlation matrix for tested variables in healthy controls. Statistically significant values are marked in red.
Group = Control
VariableCCTminFaz
Area
PerimeterCircularityCentralInnerOuterFullCMTRNFL
Symmetry
CCTmin1−0.68−0.57−0.560.870.030.190.190.720.28
Faz area−0.6810.990.87−0.760.640.50.5−0.970.44
Perimeter−0.570.9910.89−0.710.690.550.56−0.960.51
Circularity−0.560.870.891−0.580.610.470.49−0.930.44
Central0.87−0.76−0.71−0.58100.150.160.740.18
Inner0.030.640.690.61010.970.98−0.60.92
Outer0.190.50.550.470.150.9711−0.430.97
Total0.190.50.560.490.160.9811−0.440.97
CMT0.72−0.97−0.96−0.930.74−0.6−0.43−0.441−0.35
volume cube0.110.360.370.09−0.220.370.470.43−0.130.58
RNFL
symmetry
0.280.440.510.440.180.920.970.97−0.351
CCT—central corneal thickness, CMT—central macular thickness, RNFL—retinal nerve fiber layer, FAZ—foveal avascular zone.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Wylęgała, A.; Szkodny, D.; Fiolka, R.; Wylęgała, E. Assessment of the Retinal Vessels in Keratoconus: An OCT Angiography Study. J. Clin. Med. 2022, 11, 2960. https://0-doi-org.brum.beds.ac.uk/10.3390/jcm11112960

AMA Style

Wylęgała A, Szkodny D, Fiolka R, Wylęgała E. Assessment of the Retinal Vessels in Keratoconus: An OCT Angiography Study. Journal of Clinical Medicine. 2022; 11(11):2960. https://0-doi-org.brum.beds.ac.uk/10.3390/jcm11112960

Chicago/Turabian Style

Wylęgała, Adam, Dominika Szkodny, Rafał Fiolka, and Edward Wylęgała. 2022. "Assessment of the Retinal Vessels in Keratoconus: An OCT Angiography Study" Journal of Clinical Medicine 11, no. 11: 2960. https://0-doi-org.brum.beds.ac.uk/10.3390/jcm11112960

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop